Tag: India

Glenmark Received Regulatory Approval to Market Inhibitor Remogliflozin in India

Glenmark Pharmaceuticals Ltd., a research-led global integrated pharmaceutical company, announced that the company has received regulatory approval to market a combination of its novel, patent protect...

Aridis Agreed with the Serum Institute on Exclusive License to Products and MabIgX® Platform

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of targeted immunotherapies using fully human monoclonal antibodies (mAbs) to treat life-threatening ...

Glenmark, Torrent Agreed to Co-Market Remogliflozin Etabonate in India

Glenmark Pharmaceuticals Ltd. (Glenmark), and Torrent Pharmaceuticals Limited (Torrent) announced that they have entered into a non-exclusive sub-licensing agreement to co-market sodium glucose co-tra...

Value of the Russian Exports to India Exceeded $1m

At the Round table “Development of bilateral trade, banking and financial sector and industrial cooperation”, which is taking place on the sidelines of the Second Russia-India Strategic Economic Dialo...

First Indian-Chinese Working Group on Pharmaceuticals Will Take Place

India will be sending a high-level delegation to the first meeting of the working group on pharmaceuticals, with China, scheduled in Beijing next month. An initiative under the India-China Strategi...

India’s Biologic Market is Set for Strong Growth in 2019

Findings from CPhI’s bio league tables predict strong growth for India’s biologic market throughout the whole of 2019 in the build-up to CPhI India, which is set to take place later this year in Novem...

India and Cuba aimed to enhance cooperation in biotech and pharma industries

India and Cuba identified new sectors for bilateral cooperation during the recent Havana International Fair, one of the most representative business events in Latin America and the Caribbean.

India and Turkmenistan expanding pharmaceutical partnership

A meeting with an Indian delegation consisting of heads and representatives of about 30 pharmaceutical companies was held at the Union of Industrialists and Entrepreneurs of Turkmenistan. The Union...

Indian pharma manufacturers had a meeting with Russian colleagues

The event was initiated by the Council for promoting the development of export by Indian pharma manufacturers with support from the Ministry of Commerce and Industry of the Government of India.

Piramal Pharma to open its new cGMP kilo lab suite in India

Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization, announced the completion of its new cGMP kilo lab suite at its API site in Ennore (Chennai, India).

Italian API manufacturer buys a production facility in India

Olon, an API contract development and manufacturing organization and generics supplier, announced the acquisition of a local generics chemical operations API manufacturing facility in Mahad, India.

GeneSys Biologics launches an integrated drug development facilty

GeneSys Biologics, an Indian biotechnology company based in Hyderabad, launched its integrated drug development facility in Genome Valley, Shameerpet (India).

India aimed to combat with counterfeit drugs using blockchain technology

Indian policymakers in collaboration with an Indian hospital chain and a multinational technology corporation have initiated plans to deploy blockchain in the fight against counterfeit drugs.

Novo Nordisk Pharmatech signs a distribution agreement with Signet

Novo Nordisk
Novo Nordisk Pharmatech has entered into an agreement with Signet Chemical for the distribution of their pharmaceutical range of quaternary ammonium compounds in India, Bangladesh and Sri Lanka.

Iran and India will conduct 12 joint research projects

research lab
Based on previous Memoranda of Understanding inked by the two countries, 12 different joint research projects in the fields of biotechnology and water management will be carried out.

Indian pharma companies obtained 125 FDA approvals during H1 2018

Indian Pharma companies and their subsidiaries have received 125 final ANDA approvals from US FDA during the first half ended June 2018 out of total 323 Abbreviated New Drug Applications approvals.